These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 16371515)

  • 1. Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect.
    Kurth T; Walker AM; Glynn RJ; Chan KA; Gaziano JM; Berger K; Robins JM
    Am J Epidemiol; 2006 Feb; 163(3):262-70. PubMed ID: 16371515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group.
    Heuschmann PU; Berger K; Misselwitz B; Hermanek P; Leffmann C; Adelmann M; Buecker-Nott HJ; Rother J; Neundoerfer B; Kolominsky-Rabas PL; ;
    Stroke; 2003 May; 34(5):1106-13. PubMed ID: 12663875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis.
    Anaissie JE; Monlezun DJ; Siegler JE; Waring ED; Dowell LN; Samai AA; George AJ; Kimbrough T; Berthaud J; Martin-Schild S
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2603-2609. PubMed ID: 27476340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute ischemic stroke and long-term outcome after thrombolysis: nationwide propensity score-matched follow-up study.
    Schmitz ML; Simonsen CZ; Hundborg H; Christensen H; Ellemann K; Geisler K; Iversen H; Madsen C; Rasmussen MJ; Vestergaard K; Andersen G; Johnsen SP
    Stroke; 2014 Oct; 45(10):3070-2. PubMed ID: 25190440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postthrombolysis outcomes in acute ischemic stroke patients of Asian race-ethnicity.
    Mishra NK; Chan BP; Teoh HL; Meng CH; Lees KR; Chen C; Sharma VK;
    Int J Stroke; 2013 Oct; 8 Suppl A100():95-9. PubMed ID: 23490069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
    Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.
    Al-Khaled M; Matthis C; Eggers J
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):7-11. PubMed ID: 22578915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis.
    Adeoye O; Sucharew H; Khoury J; Tomsick T; Khatri P; Palesch Y; Schmit PA; Pancioli AM; Broderick JP;
    Stroke; 2015 Feb; 46(2):461-4. PubMed ID: 25523054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of edaravone on early outcomes in acute ischemic stroke patients treated with recombinant tissue plasminogen activator.
    Wada T; Yasunaga H; Inokuchi R; Horiguchi H; Fushimi K; Matsubara T; Nakajima S; Yahagi N
    J Neurol Sci; 2014 Oct; 345(1-2):106-11. PubMed ID: 25085762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy.
    Heuschmann PU; Kolominsky-Rabas PL; Roether J; Misselwitz B; Lowitzsch K; Heidrich J; Hermanek P; Leffmann C; Sitzer M; Biegler M; Buecker-Nott HJ; Berger K;
    JAMA; 2004 Oct; 292(15):1831-8. PubMed ID: 15494580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
    Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
    Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter Study of Intravenous Recombinant Tissue Plasminogen Activator Infusion around Hiroshima, Japan: The Hiroshima Acute Stroke Retrospective and Prospective Registry Study.
    Aoki S; Hosomi N; Sueda Y; Kono T; Takamatsu K; Ohyama H; Torii T; Kitamura T; Nomura E; Noda K; Ohtsuki T; Matsumoto M;
    J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2747-53. PubMed ID: 26360972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Antidepressant Treatment and All-Cause 30-Day Mortality in Patients with Ischemic Stroke.
    Mortensen JK; Johnsen SP; Larsson H; Andersen G
    Cerebrovasc Dis; 2015; 40(1-2):81-90. PubMed ID: 26184925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional outcome after primary endovascular therapy or IV thrombolysis alone for stroke. An observational, comparative effectiveness study.
    Abilleira S; Ribera A; Dávalos A; Ribó M; Chamorro A; Cardona P; Molina CA; Martínez-Yélamos A; Urra X; Dorado L; Roquer J; Martí-Fàbregas J; Aja L; Tomasello A; Castaño C; Blasco J; Cánovas D; Castellanos M; Krupinski J; Guimaraens L; Perendreu J; Ustrell X; Purroy F; Gómez-Choco M; Baiges JJ; Cocho D; Saura J; Gallofré M;
    Cerebrovasc Dis; 2014; 38(5):328-36. PubMed ID: 25428822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Association between t-PA Administration and In-Hospital Mortality following Acute Ischemic Stroke in Puerto Rican Patients.
    Shah K; Kohrman S; Alkhatib S; González J; Santiago F; Varella M; Zevallos J
    P R Health Sci J; 2016 Dec; 35(4):215-219. PubMed ID: 27898168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of a contemporary cohort of 536 consecutive patients with acute ischemic stroke treated with endovascular therapy.
    Abilleira S; Cardona P; Ribó M; Millán M; Obach V; Roquer J; Cánovas D; Martí-Fàbregas J; Rubio F; Alvarez-Sabín J; Dávalos A; Chamorro A; de Miquel MA; Tomasello A; Castaño C; Macho JM; Ribera A; Gallofré M;
    Stroke; 2014 Apr; 45(4):1046-52. PubMed ID: 24595590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased benefit of alteplase in patients with ischemic stroke and a high body temperature.
    de Ridder I; den Hertog H; van Gemert M; Dippel D; van der Worp B;
    Cerebrovasc Dis; 2013; 35(1):60-3. PubMed ID: 23428998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting clinical outcomes after thrombolysis using the iScore: results from the Virtual International Stroke Trials Archive.
    Saposnik G; Reeves MJ; Johnston SC; Bath PM; Ovbiagele B;
    Stroke; 2013 Oct; 44(10):2755-9. PubMed ID: 23887844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved ischemic stroke outcome prediction using model estimation of outcome probability: the THRIVE-c calculation.
    Flint AC; Rao VA; Chan SL; Cullen SP; Faigeles BS; Smith WS; Bath PM; Wahlgren N; Ahmed N; Donnan GA; Johnston SC;
    Int J Stroke; 2015 Aug; 10(6):815-21. PubMed ID: 26045081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.